A detailed history of Woodline Partners LP transactions in Allogene Therapeutics, Inc. stock. As of the latest transaction made, Woodline Partners LP holds 4,364,300 shares of ALLO stock, worth $10.7 Million. This represents 0.11% of its overall portfolio holdings.

Number of Shares
4,364,300
Previous 4,358,989 0.12%
Holding current value
$10.7 Million
Previous $10.2 Million 20.32%
% of portfolio
0.11%
Previous 0.1%

Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$2.08 - $3.5 $11,046 - $18,588
5,311 Added 0.12%
4,364,300 $12.2 Million
Q2 2024

Aug 14, 2024

BUY
$2.23 - $4.38 $3.85 Million - $7.56 Million
1,725,013 Added 65.49%
4,358,989 $10.2 Million
Q1 2024

May 15, 2024

BUY
$2.92 - $5.63 $164,909 - $317,959
56,476 Added 2.19%
2,633,976 $11.8 Million
Q4 2023

Feb 14, 2024

SELL
$2.28 - $3.5 $6.24 Million - $9.58 Million
-2,736,415 Reduced 51.5%
2,577,500 $8.27 Million
Q3 2023

Nov 14, 2023

BUY
$3.17 - $5.96 $1,315 - $2,473
415 Added 0.01%
5,313,915 $16.8 Million
Q2 2023

Aug 14, 2023

BUY
$4.53 - $6.74 $14.1 Million - $21 Million
3,121,070 Added 142.36%
5,313,500 $26.4 Million
Q1 2023

May 15, 2023

SELL
$4.92 - $8.21 $3.59 Million - $5.99 Million
-729,032 Reduced 24.95%
2,192,430 $10.8 Million
Q4 2022

Feb 14, 2023

SELL
$5.62 - $11.11 $9.02 Million - $17.8 Million
-1,604,960 Reduced 35.46%
2,921,462 $18.4 Million
Q3 2022

Nov 14, 2022

SELL
$10.32 - $17.28 $13.8 Million - $23 Million
-1,333,257 Reduced 22.75%
4,526,422 $48.9 Million
Q2 2022

Aug 15, 2022

BUY
$6.78 - $12.28 $36.8 Million - $66.7 Million
5,427,529 Added 1255.94%
5,859,679 $66.8 Million
Q1 2022

May 16, 2022

SELL
$7.65 - $15.29 $519,779 - $1.04 Million
-67,945 Reduced 13.59%
432,150 $3.94 Million
Q4 2021

Feb 14, 2022

SELL
$13.13 - $24.52 $4.1 Million - $7.67 Million
-312,635 Reduced 38.47%
500,095 $7.46 Million
Q3 2021

Nov 15, 2021

BUY
$21.01 - $27.64 $2.69 Million - $3.54 Million
127,975 Added 18.69%
812,730 $20.9 Million
Q2 2021

Aug 16, 2021

BUY
$23.49 - $35.8 $284,487 - $433,573
12,111 Added 1.8%
684,755 $17.9 Million
Q1 2021

May 17, 2021

BUY
$25.79 - $39.02 $2.71 Million - $4.1 Million
105,105 Added 18.52%
672,644 $23.7 Million
Q4 2020

Feb 16, 2021

BUY
$25.24 - $43.45 $4.22 Million - $7.27 Million
167,306 Added 41.8%
567,539 $14.3 Million
Q3 2020

Nov 16, 2020

BUY
$32.38 - $44.96 $8.79 Million - $12.2 Million
271,605 Added 211.16%
400,233 $15.1 Million
Q2 2020

Aug 14, 2020

BUY
$18.39 - $54.04 $2.37 Million - $6.95 Million
128,628 New
128,628 $5.51 Million

Others Institutions Holding ALLO

About Allogene Therapeutics, Inc.


  • Ticker ALLO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 143,807,008
  • Market Cap $354M
  • Description
  • Allogene Therapeutics, Inc., a clinical stage immuno-oncology company, develops and commercializes genetically engineered allogeneic T cell therapies for the treatment of cancer. It develops, manufactures, and commercializes UCART19, an allogeneic chimeric antigen receptor (CAR) T cell product candidate for the treatment of pediatric and adult p...
More about ALLO
Track This Portfolio

Track Woodline Partners LP Portfolio

Follow Woodline Partners LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Woodline Partners LP, based on Form 13F filings with the SEC.

News

Stay updated on Woodline Partners LP with notifications on news.